C31 Intrinsic Valuation and Fundamental Analysis - Cooper-Standard Holdings Inc

C	Cooper-Standard Holdings Inc SWB:C31	US
S	Sarepta Therapeutics Inc F:AB3A	US

Intrinsic Value

The intrinsic value for Cooper-Standard Holdings Inc (C31) under the Base Case is 69.29 EUR. Compared with the current market price of 26.24 EUR, the stock appears Undervalued by 62% .

DCF Value

€49.41

Multiples-Based Value

€89.17

DCF Value

€49.41

Multiples-Based Value

€89.17

Both DCF and multiples point to undervaluation.

Why combine DCF with multiples? What is Intrinsic Value?

C31 Intrinsic Value

Undervaluation 62%

Intrinsic Value

Price €26.24

Bear Case

Base Case

Bull Case

Track Buy Zone

20% below Intrinsic Value €55.43

Get notified when the price drops into your buy zone

Intrinsic Value €69.29

Margin of Safety 20% €55.43

Current Price €26.24

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Cooper-Standard Holdings Inc.

Explain Valuation